Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11096166 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Placebo;   Drug: Infliximab 3 mg/kg;   Drug: Infliximab 10 mg/kg

Indicates status has not been verified in more than two years